| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700279 | Clinical Oncology | 2006 | 6 Pages |
Abstract
EBXRT may be offered for T1-2 cancer of the penis with close surveillance to detect local recurrences early for salvage surgery without jeopardising overall survival. It remains an alternative option to penis-preserving surgery and should be discussed in a multidisciplinary setting and with the patient.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Azrif, J.P. Logue, R. Swindell, R.A. Cowan, J.P. Wylie, J.E. Livsey,